TA140 Ulcerative colitis (subacute manifestations) - infliximab: understanding NICE guidance
The summary of the key recommendations of the technology appraisal on Ulcerative colitis (subacute manifestations) - infliximab . It is written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets or any other suitable publication.
|
|
TA140 Ulcerative colitis (subacute manifestations) - infliximab: understanding NICE guidance
23 April 2008 (85.6 Kb 24 sec) |
